What is the recommended dosing for Tessalon (Benzonatate) pearls in a patient with a cough, considering factors such as age, weight, medical history, and potential interactions with other medications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tessalon (Benzonatate) Dosing

The standard adult dose of benzonatate (Tessalon Perles) is 100-200 mg orally three times daily, with a maximum daily dose of 600 mg. 1, 2

Standard Dosing Regimen

  • Adults and children over 10 years: 100-200 mg orally three times daily (every 8 hours) as needed for cough 1, 2
  • Maximum daily dose: 600 mg (three 200 mg doses) 1, 2
  • Children under 10 years: Benzonatate is contraindicated due to risk of fatal overdose 3, 4

Critical Safety Warnings

Life-Threatening Risks

  • Capsules must be swallowed whole and never chewed, crushed, or dissolved - doing so releases the medication rapidly and can cause severe local anesthesia of the oral mucosa, choking, and potentially fatal outcomes 3, 4
  • Accidental ingestion in children can be rapidly fatal - even small amounts have caused death in infants and young children within 1 hour 3, 4
  • Overdose in adults can cause cardiac arrest - ingestion of less than 30 capsules (6000 mg) has resulted in cardiac arrest, severe acidosis, and death 4

Common Adverse Effects

  • Local numbness or tingling of the mouth and throat if capsule is chewed 5
  • Sedation and dizziness 6
  • Gastrointestinal upset 6

Clinical Position in Treatment Algorithm

Benzonatate is a fourth-line agent reserved for refractory cough that has failed multiple other therapies. 1, 2

Recommended Treatment Sequence:

  1. First-line: Simple remedies (honey and lemon) or dextromethorphan 30-60 mg 1, 7
  2. Second-line: Opioid derivatives (codeine, hydrocodone) if dextromethorphan fails 2
  3. Third-line: Peripherally-acting antitussives (levodropropizine, moguisteine) 2
  4. Fourth-line: Benzonatate 100-200 mg four times daily OR nebulized lidocaine 1, 2

When to Consider Benzonatate

  • Opioid-resistant cough - particularly effective when codeine and other opioids have failed 5
  • Patients requiring non-opioid alternatives - useful when opioid side effects are intolerable or opioids are contraindicated 6, 5
  • Cancer-associated cough - shown 80% effectiveness in malignant pulmonary involvement unresponsive to opioids 2, 6

Special Populations

Renal Impairment

  • No dose adjustment required - benzonatate is not renally excreted 1

Geriatric Patients

  • Assess aspiration risk before prescribing - local anesthetic effects increase aspiration risk in frail elderly patients 2
  • Use standard adult dosing but monitor closely for adverse effects 2

Pregnancy and Lactation

  • Limited safety data available - use only if benefit clearly outweighs risk 6

Common Prescribing Pitfalls to Avoid

  • Do not use as first-line therapy - benzonatate should only be tried after failure of simpler, safer agents like dextromethorphan 1, 2, 7
  • Do not prescribe for children under 10 years - risk of fatal toxicity is too high 3, 4
  • Warn patients explicitly about swallowing capsules whole - chewing or dissolving can be life-threatening 3, 4
  • Do not continue indefinitely without reassessment - if no improvement after a short trial, discontinue and try alternative approaches 1
  • Store securely away from children - accidental pediatric ingestion has caused rapid death 3, 4

Duration of Therapy

  • Use for short-term symptomatic relief only 1
  • If cough persists beyond 3 weeks despite treatment, discontinue benzonatate and pursue full diagnostic workup for underlying causes 1
  • Reassess need for continued therapy regularly rather than prescribing chronic refills 1

References

Guideline

Medications for Acute Cough in the Emergency Department

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Inhaled Lidocaine for Refractory Cough

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Two fatalities resulting from Tessalon (benzonatate).

Veterinary and human toxicology, 1986

Research

Cardiac Arrest Due to Benzonatate Overdose.

The American journal of case reports, 2019

Research

Important drugs for cough in advanced cancer.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2001

Guideline

Management of Dry Cough

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.